American National Bank & Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19M | Sell |
15,875
-139
| -0.9% | -$142K | 1.63% | 16 |
|
|
2026
Q1 | $14.7M | Buy |
16,014
+103
| +0.6% | +$104K | 1.41% | 21 |
|
|
2025
Q4 | $17.1M | Sell |
15,911
-264
| -2% | -$252K | 1.62% | 16 |
|
|
2025
Q3 | $12.3M | Sell |
16,175
-1,340
| -8% | -$997K | 1.22% | 26 |
|
|
2025
Q2 | $13.7M | Buy |
17,515
+3,368
| +24% | +$2.62M | 1.4% | 22 |
|
|
2025
Q1 | $11.7M | Buy |
14,147
+6,219
| +78% | +$5.17M | 1.3% | 26 |
|
|
2024
Q4 | $6.12M | Buy |
7,928
+1,347
| +20% | +$1.12M | 0.68% | 45 |
|
|
2024
Q3 | $5.83M | Sell |
6,581
-14
| -0.2% | -$12.6K | 0.69% | 44 |
|
|
2024
Q2 | $5.97M | Buy |
6,595
+100
| +2% | +$80K | 0.74% | 41 |
|
|
2024
Q1 | $5.05M | Sell |
6,495
-224
| -3% | -$159K | 0.67% | 45 |
|
|
2023
Q4 | $3.92M | Sell |
6,719
-1,959
| -23% | -$1.14M | 0.62% | 48 |
|
|
2023
Q3 | $4.66M | Sell |
8,678
-578
| -6% | -$298K | 0.79% | 43 |
|
|
2023
Q2 | $4.34M | Sell |
9,256
-901
| -9% | -$378K | 0.73% | 45 |
|
|
2023
Q1 | $3.49M | Buy |
10,157
+633
| +7% | +$213K | 0.64% | 49 |
|
|
2022
Q4 | $3.48M | Buy |
9,524
+374
| +4% | +$133K | 0.71% | 46 |
|
|
2022
Q3 | $2.96M | Sell |
9,150
-54
| -0.6% | -$17.1K | 0.71% | 43 |
|
|
2022
Q2 | $2.98M | Sell |
9,204
-19
| -0.2% | -$5.7K | 0.71% | 42 |
|
|
2022
Q1 | $2.64M | Sell |
9,223
-757
| -8% | -$195K | 0.52% | 48 |
|
|
2021
Q4 | $2.76M | Buy |
9,980
+548
| +6% | +$139K | 0.54% | 46 |
|
|
2021
Q3 | $2.18M | Buy |
9,432
+11
| +0.1% | +$2.71K | 0.48% | 46 |
|
|
2021
Q2 | $2.16M | Buy |
9,421
+1,343
| +17% | +$270K | 0.46% | 46 |
|
|
2021
Q1 | $1.51M | Buy |
8,078
+868
| +12% | +$170K | 0.36% | 47 |
|
|
2020
Q4 | $1.22M | Hold |
7,210
| – | – | 0.31% | 50 |
|
|
2020
Q3 | $1.07M | Buy |
7,210
+1,030
| +17% | +$159K | 0.3% | 46 |
|
|
2020
Q2 | $1.01M | Sell |
6,180
-465
| -7% | -$71.4K | 0.33% | 46 |
|
|
2020
Q1 | $922K | Buy |
6,645
+5,535
| +499% | +$761K | 0.36% | 46 |
|
|
2019
Q4 | $146K | Buy |
1,110
+420
| +61% | +$48.7K | 0.04% | 99 |
|
|
2019
Q3 | $77K | Hold |
690
| – | – | 0.02% | 110 |
|
|
2019
Q2 | $76K | Hold |
690
| – | – | 0.02% | 111 |
|
|
2019
Q1 | $90K | Sell |
690
-4,536
| -87% | -$552K | 0.03% | 113 |
|
|
2018
Q4 | $605K | Hold |
5,226
| – | – | 0.22% | 62 |
|
|
2018
Q3 | $561K | Buy |
5,226
+245
| +5% | +$24.5K | 0.16% | 74 |
|
|
2018
Q2 | $425K | Sell |
4,981
-57
| -1% | -$4.68K | 0.12% | 98 |
|
|
2018
Q1 | $390K | Buy |
5,038
+588
| +13% | +$47.3K | 0.11% | 96 |
|
|
2017
Q4 | $376K | Buy |
4,450
+2,362
| +113% | +$201K | 0.11% | 101 |
|
|
2017
Q3 | $179K | Hold |
2,088
| – | – | 0.05% | 109 |
|
|
2017
Q2 | $172K | Buy |
2,088
+104
| +5% | +$8.48K | 0.06% | 110 |
|
|
2017
Q1 | $167K | Sell |
1,984
-1,771
| -47% | -$142K | 0.05% | 108 |
|
|
2016
Q4 | $276K | Buy |
3,755
+1,225
| +48% | +$91.2K | 0.09% | 87 |
|
|
2016
Q3 | $203K | Buy |
2,530
+350
| +16% | +$28K | 0.07% | 89 |
|
|
2016
Q2 | $172K | Sell |
2,180
-567
| -21% | -$42.7K | 0.06% | 95 |
|
|
2016
Q1 | $198K | Hold |
2,747
| – | – | 0.07% | 83 |
|
|
2015
Q4 | $231K | Hold |
2,747
| – | – | 0.09% | 80 |
|
|
2015
Q3 | $230K | Hold |
2,747
| – | – | 0.1% | 84 |
|
|
2015
Q2 | $229K | Hold |
2,747
| – | – | 0.09% | 79 |
|
|
2015
Q1 | $199K | Buy |
2,747
+340
| +14% | +$24.2K | 0.08% | 82 |
|
|
2014
Q4 | $166K | Hold |
2,407
| – | – | 0.06% | 93 |
|
|
2014
Q3 | $156K | Buy |
+2,407
| New | +$152K | 0.06% | 87 |
|
Other funds holding LLY
SC
ONB
GIM
American National Bank & Trust's LLY Position: Q2 2026 in Review
American National Bank & Trust reduced its Eli Lilly (LLY) stake by 0.87% in Q2 2026, selling an estimated $142K and leaving 15,875 shares worth $19M. The position accounts for 1.63% of the portfolio, ranked #16.
American National Bank & Trust first reported a position in LLY in Q3 2014 and has held it in 48 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- American National Bank & Trust held 15,875 shares of Eli Lilly worth $19M as of Q2 2026.
- American National Bank & Trust sold 139 Eli Lilly shares in Q2 2026, an estimated $142K.
- Eli Lilly made up 1.63% of American National Bank & Trust's portfolio in Q2 2026, its #16 holding.
- American National Bank & Trust first reported a position in Eli Lilly in Q3 2014 and has held it in 48 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.